原发性肝癌TACE术后的并发症及治疗

Complications and treatment of primary liver cancer after TACE

原发性肝癌起病隐匿,早中期肝癌患者症状不明显,因症状就诊时,往往已属肿瘤中晚期,很多患者因此失去手术切除机会。目前经导管肝动脉灌注化疗栓塞(TACE)是原发性肝癌非手术治疗的一线方案之一,有创伤相对较小、效果较好、可多次重复治疗等特点,对于中晚期肝癌有较确切的疗效,大大延长了肝癌患者整体生存时间。但TACE治疗过程中仍有不少并发症需要注意,本文归纳了TACE术后的并发症。通过提前预防或及时干预相关并发症,以期在临床治疗过程中减少并发症及其程度,提高肝癌的治疗质量。

The onset of primary liver cancer is hidden,and the symptoms of patients with early and middle stage liver cancer are not obvious.Many patients have lost the opportunity of surgical resection because they are in the middle and late stage of the tumor when they go to hospital for symptoms.At present,transcatheter arterial chemoembolization(TACE)is one of the first-line non-surgical treatment schemes for primary liver cancer.It has the characteristics of relatively smaller trauma,better efficacy,repeated treatment and so on.It has a definite therapeutic efficacy for liver cancer in the middle and late stage and greatly prolongs the overall survival time of liver cancer patients.However,there are still many complications that require attention in the course of TACE treatment.The complications after TACE operation are summarized in this paper.By preventing the related complications in advance or intervening in time,we hope to reduce the complications and their degree in the clinical treatment process and improve the treatment quality of liver cancer.